Matches in SemOpenAlex for { <https://semopenalex.org/work/W2509721915> ?p ?o ?g. }
- W2509721915 endingPage "3131" @default.
- W2509721915 startingPage "3125" @default.
- W2509721915 abstract "The live-attenuated oral polio vaccine (OPV) will be no longer used when wild poliovirus (WPV) eliminating in worldwide, according to GPEI (the Global Polio Eradication Initiative) Reports. It is planning to replace OPV by Sabin-based inactivated poliovirus vaccine (sIPV) in developing countries, with purpose of reducing of the economic burden and maintaining of the appropriate antibody levels in population. It studied serial fractional doses immunized by intradermal injection (ID) in rats, to reduce consume of antigen and financial burden, maintaining sufficient immunogenicity; Methods: Study groups were divided in 4 groups of dose gradient, which were one-tenth (1/10), one-fifth (1/5), one-third (1/3) and one-full dose (1/1), according to the volume of distribution taken from the same batch of vaccine (sIPV). Wistar rats were injected intradermally with the needle and syringe sing the mantoux technique taken once month for 3 times. It was used as positive control that intramuscular inoculation (IM) was injected with one-full dose (1/1) with same batch of sIPV. PBS was used as negative control. Blood samples were collected via tail vein. After 30 d with 3 round of immunization, it analyzed the changes of neutralization antibody titers in the each group by each immunization program end; Results: The results of seroconversion had positive correlation with different doses in ID groups. The higher concentration of D-antigen (D-Ag) could conduct higher seroconversion. Furthermore, different types of viruses had different seroconversion trend. It showed that the geometric mean titers (GMTs) of each fractional-dose ID groups increased by higher concentration of D-Ag, and it got significant lower than the full-dose IM group. At 90th days of immunization, the GMTs for each poliovirus subtypes of fractional doses were almost higher than 1:8, implied that it could be meaning positive seroprotection titer for polio vaccine types, according to WHO suggestion; Conclusions: The fractional dose with one-fifth (1/5) could be used by intradermal injection to prevent poliovirus infection, if there were more human clinical detail research consistent with this findings in rats." @default.
- W2509721915 created "2016-09-16" @default.
- W2509721915 creator A5006669237 @default.
- W2509721915 creator A5013693999 @default.
- W2509721915 creator A5018620202 @default.
- W2509721915 creator A5019236431 @default.
- W2509721915 creator A5027333093 @default.
- W2509721915 creator A5031371726 @default.
- W2509721915 creator A5033480643 @default.
- W2509721915 creator A5035282947 @default.
- W2509721915 creator A5054856233 @default.
- W2509721915 creator A5068311586 @default.
- W2509721915 creator A5090998568 @default.
- W2509721915 date "2016-08-15" @default.
- W2509721915 modified "2023-09-23" @default.
- W2509721915 title "Analyzed immunogenicity of fractional doses of Sabin-inactivated poliovirus vaccine (sIPV) with intradermal delivery in rats" @default.
- W2509721915 cites W1929887970 @default.
- W2509721915 cites W1970906496 @default.
- W2509721915 cites W2010129113 @default.
- W2509721915 cites W2020809345 @default.
- W2509721915 cites W2028653503 @default.
- W2509721915 cites W2032193013 @default.
- W2509721915 cites W2035206932 @default.
- W2509721915 cites W2036533635 @default.
- W2509721915 cites W2055509052 @default.
- W2509721915 cites W2055651797 @default.
- W2509721915 cites W2062558852 @default.
- W2509721915 cites W2082884420 @default.
- W2509721915 cites W2091600400 @default.
- W2509721915 cites W2098993743 @default.
- W2509721915 cites W2105468480 @default.
- W2509721915 cites W2114052316 @default.
- W2509721915 cites W2117691753 @default.
- W2509721915 cites W2131137767 @default.
- W2509721915 cites W2134095241 @default.
- W2509721915 cites W2142317414 @default.
- W2509721915 cites W2148505903 @default.
- W2509721915 cites W2164200853 @default.
- W2509721915 cites W2268576406 @default.
- W2509721915 cites W2269774938 @default.
- W2509721915 cites W2293145130 @default.
- W2509721915 cites W2293171884 @default.
- W2509721915 cites W2314346321 @default.
- W2509721915 cites W2420799073 @default.
- W2509721915 cites W4298381980 @default.
- W2509721915 cites W4301956201 @default.
- W2509721915 doi "https://doi.org/10.1080/21645515.2016.1214347" @default.
- W2509721915 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5215542" @default.
- W2509721915 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27558963" @default.
- W2509721915 hasPublicationYear "2016" @default.
- W2509721915 type Work @default.
- W2509721915 sameAs 2509721915 @default.
- W2509721915 citedByCount "5" @default.
- W2509721915 countsByYear W25097219152018 @default.
- W2509721915 countsByYear W25097219152022 @default.
- W2509721915 countsByYear W25097219152023 @default.
- W2509721915 crossrefType "journal-article" @default.
- W2509721915 hasAuthorship W2509721915A5006669237 @default.
- W2509721915 hasAuthorship W2509721915A5013693999 @default.
- W2509721915 hasAuthorship W2509721915A5018620202 @default.
- W2509721915 hasAuthorship W2509721915A5019236431 @default.
- W2509721915 hasAuthorship W2509721915A5027333093 @default.
- W2509721915 hasAuthorship W2509721915A5031371726 @default.
- W2509721915 hasAuthorship W2509721915A5033480643 @default.
- W2509721915 hasAuthorship W2509721915A5035282947 @default.
- W2509721915 hasAuthorship W2509721915A5054856233 @default.
- W2509721915 hasAuthorship W2509721915A5068311586 @default.
- W2509721915 hasAuthorship W2509721915A5090998568 @default.
- W2509721915 hasBestOaLocation W25097219151 @default.
- W2509721915 hasConcept C147483822 @default.
- W2509721915 hasConcept C151492266 @default.
- W2509721915 hasConcept C159047783 @default.
- W2509721915 hasConcept C159654299 @default.
- W2509721915 hasConcept C203014093 @default.
- W2509721915 hasConcept C22070199 @default.
- W2509721915 hasConcept C2522874641 @default.
- W2509721915 hasConcept C2777451964 @default.
- W2509721915 hasConcept C2779631682 @default.
- W2509721915 hasConcept C2780801004 @default.
- W2509721915 hasConcept C2780868878 @default.
- W2509721915 hasConcept C2908647359 @default.
- W2509721915 hasConcept C32611913 @default.
- W2509721915 hasConcept C4870876 @default.
- W2509721915 hasConcept C71924100 @default.
- W2509721915 hasConcept C99454951 @default.
- W2509721915 hasConceptScore W2509721915C147483822 @default.
- W2509721915 hasConceptScore W2509721915C151492266 @default.
- W2509721915 hasConceptScore W2509721915C159047783 @default.
- W2509721915 hasConceptScore W2509721915C159654299 @default.
- W2509721915 hasConceptScore W2509721915C203014093 @default.
- W2509721915 hasConceptScore W2509721915C22070199 @default.
- W2509721915 hasConceptScore W2509721915C2522874641 @default.
- W2509721915 hasConceptScore W2509721915C2777451964 @default.
- W2509721915 hasConceptScore W2509721915C2779631682 @default.
- W2509721915 hasConceptScore W2509721915C2780801004 @default.
- W2509721915 hasConceptScore W2509721915C2780868878 @default.
- W2509721915 hasConceptScore W2509721915C2908647359 @default.
- W2509721915 hasConceptScore W2509721915C32611913 @default.